|
NIH/BMGF Collaboration - Point of Care Testing Working Group
|
Committee, Work group, Advisory group, or Task Force
|
CMS, FDA
|
NIBIB, NCI, NIAID, NICHD
|
The National Institute of Biomedical Imaging and Bioengineering (NIBIB) co-chairs the National Institutes of Health (NIH) Bill and Melinda Gates Foundation Working Group on Point of Care (POC) Diagnostics. This group of government and private partners is working to identify and collaborate on projects to develop diagnostic tests for low resource areas. One area of focus is to leverage resources for the development of a rapid POC diagnostic test for viral infections such as HIV or influenza. NIBIB hosted a working group session on March 30, 2017, that focused on patient access to health diagnostics. Ideas from this session were presented at the larger NIH-BMGF meeting on June 30, 2017, hosted by NIH.
|
|
Northwest Portland Tribal Registry Project
|
Resource Development
|
IHS
|
NCI
|
Over the past 10 years, health care delivery for Northwest American Indians and Alaska Natives (AI/AN) has evolved from a centralized system maintained by the Indian Health Service (IHS) to a diverse and complex environment. The Northwest Tribal Registry Project was developed in January 1999 by the Northwest Tribal Epidemiology Center, a tribally operated program located at the Northwest Portland Area Indian Health Board (NPAIHB) in Portland, Oregon. The Project works with state health organizations to correct racial misclassification for AI/AN in disease registries, obtain accurate estimates of the cancer burden, and to generate health status information for tribes and health programs. NCI contributes funding to the IHS for this project through the Native American Research Centers for Health (NARCH) program.
|
|
NSTC Subcommittee on Biological Sciences
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA, OS
|
OD/OSP
|
Advises and assists the Committee on Science and the NSTC on Federal policies, procedures and plans in the biological sciences; also explore ways in which the Federal government can increase the overall effectiveness and productivity of its investment in biological sciences research, especially regarding issues that cut across agency boundaries.
|
|
Nutrition Research Coordinating Committee
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA, HRSA, IHS, OS
|
NIDDK, CC, CIT, CSR, FIC, NCATS, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/DPCPSI/ODP, OD/DPCPSI/ODS
|
The Nutrition Research Coordinating Committee (NRCC) was established by the NIH Office of the Director in 1975 to improve communication and research coordination of nutrition activities within the NIH and across the federal government. Today it provides an open forum for members to discuss current and future nutrition research challenges and opportunities. The NRCC has broad representation from the NIH institutes and centers. In addition, liaisons from other federal offices and agencies also participate. The NRCC meets monthly, alternating between intra-NIH and interagency meetings. NRCC membership is open to any federal staff member interested in carrying out any trans-NIH or trans-agency nutrition research efforts. NRCC meetings are chaired by the Director of the NIDDK Office of Nutrition Research.
|
|
Obesity Prevention and Control: Combined School-Based Interventions to Increase Healthier Food and Beverage Consumption and Physical Activity
|
Meeting/ Workshop
|
CDC
|
NHLBI
|
Ongoing participation on monthly calls by the Community Guide Coordinating Team.
|
|
Observational Cohort to Assess Therapeutic Efficacy and Emergence of HIV Drug Resistance following Initiation of Tenofovir-Lamivudine-Dolutegravir (TLD)
|
Research Initiative
|
CDC
|
NIAID
|
This is a study of the safety, adherence, and efficacy of a fixed-dose combination of drug tenofovir/lamivudine/dolutegravir (TLD) among HIV patients, including those co-infected with tuberculosis, receiving care at PEPFAR (President’s Emergency Plan for AIDS Relief) funded sites in resource limited countries.
|
|
Obstetrics and Gynecology Devices Advisory Committee
|
Committee, Work group, Advisory group, or Task Force
|
FDA
|
NICHD
|
The Obstetrics and Gynecology Devices Panel reviews and evaluates data concerning the safety and effectiveness of marketed and investigational devices for use in obstetrics and gynecology and makes appropriate recommendations to the Commissioner of Food and Drugs.
|
|
Office for Human Research Protections/Office of Extramural Research Training Initiative
|
Meeting/ Workshop
|
OS
|
OD/OER
|
The National Institutes of Health collaborated with the Office for Human Research Protections to provide comprehensive training at both NIH Regional Meetings for the extramural community.
|
|
Office of AIDS Research Advisory Council (OARAC)
|
Committee, Work group, Advisory group, or Task Force
|
CDC
|
OD/DPCPSI/OAR, NCI, NIAID, NIDA, NIMH
|
The Office of AIDS Research Advisory Council (OARAC) advises the Director of the Office for AIDS Research, the Director of the National Institutes of Health (NIH), and the Secretary of the Department of Health and Human Services on the planning, coordination, and evaluation of all HIV/AIDS research programs and related activities at the NIH. The OARAC also advises on the AIDS research policies and priorities, the development of an annual plan for HIV-related research, and the coordination of HHS agency-wide HIV/AIDS efforts.
|
|
Office of Justice Programs/HHS Medicolegal Death Investigation Working Group
|
Committee, Work group, Advisory group, or Task Force
|
CDC
|
NIAID, CC, NICHD
|
Identify short and long term goals to develop and implement programmatic activities that support the Medicolegal Death Investigation system.
|